Evidence map›Paper›PMID 28887323›Full record

ArticleCancer research2017

ATG5 Mediates a Positive Feedback Loop between Wnt Signaling and Autophagy in Melanoma.

Abibatou Ndoye, Anna Budina-Kolomets, Curtis H Kugel, Marie R Webster, Amanpreet Kaur, Reeti Behera, Vito W Rebecca, Ling Li, Patricia A Brafford, Qin Liu and 12 more

Open access · bronzeAbstract read
In one paragraph

Article in Cancer research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 39 citations in OpenAlex.

  1. Radioresistance Mechanisms in Head and Neck Cancer.Clinical and experimental otorhinolaryngology · 2025
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. WNT Signaling in Melanoma.International journal of molecular sciences · 2020
    Review
  17. Article
  18. Article
  19. Non-Apoptotic Cell Death Signaling Pathways in Melanoma.International journal of molecular sciences · 2020
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 2 institutions in 1 country.

Abibatou NdoyeThe Wistar Institute Melanoma Research Center, Philadelphia, Pennsylvania.
Anna Budina-KolometsThe Wistar Institute Melanoma Research Center, Philadelphia, Pennsylvania.
Curtis H KugelThe Wistar Institute Melanoma Research Center, Philadelphia, Pennsylvania.
Marie R WebsterThe Wistar Institute Melanoma Research Center, Philadelphia, Pennsylvania.
Amanpreet KaurThe Wistar Institute Melanoma Research Center, Philadelphia, Pennsylvania.
Reeti BeheraThe Wistar Institute Melanoma Research Center, Philadelphia, Pennsylvania.
Vito W RebeccaThe University of Pennsylvania, Philadelphia, Pennsylvania.
Ling LiThe Wistar Institute Melanoma Research Center, Philadelphia, Pennsylvania.
Patricia A BraffordThe Wistar Institute Melanoma Research Center, Philadelphia, Pennsylvania.
Qin LiuThe Wistar Institute Melanoma Research Center, Philadelphia, Pennsylvania.
Y N Vashisht GopalThe University of Texas MD Anderson Cancer Center, Houston, Texas.
Michael A DaviesThe University of Texas MD Anderson Cancer Center, Houston, Texas.
Gordon B MillsThe University of Texas MD Anderson Cancer Center, Houston, Texas.
Xiaowei XuThe University of Pennsylvania, Philadelphia, Pennsylvania.
Hong WuFox Chase Cancer Center, Philadelphia, Pennsylvania.
Meenhard HerlynThe Wistar Institute Melanoma Research Center, Philadelphia, Pennsylvania.
Michael C NicastriThe University of Pennsylvania, Philadelphia, Pennsylvania.
Jeffrey D WinklerThe University of Pennsylvania, Philadelphia, Pennsylvania.
Maria S SoengasMelanoma Group, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
Ravi K AmaravadiThe University of Pennsylvania, Philadelphia, Pennsylvania.
Maureen E MurphyThe Wistar Institute Melanoma Research Center, Philadelphia, Pennsylvania.
Ashani T WeeraratnaThe Wistar Institute Melanoma Research Center, Philadelphia, Pennsylvania. aweeraratna@wistar.org.
The University of Texas MD Anderson Cancer Center · USFox Chase Cancer Center · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
Tumor Microenvironment and MetastasisP30CA010815 · NCI · WISTAR INSTITUTE · PI Luis J Montaner · 1985 to 2026
$75.9M
Targeting the MAP and PI3 Kinase Pathways in MelanomaP01CA114046 · NCI · WISTAR INSTITUTE · PI WEERARATNA, ASHANI T · 2008 to 2023
$37.1M
Tissue &PathologyP50CA093372 · NCI · WISTAR INSTITUTE · PI HERLYN, MEENHARD F · 2001 to 2009
$15.4M
TRAINING PROGRAM IN BASIC CANCER RESEARCHT32CA009171 · NCI · WISTAR INSTITUTE · PI Alessandro Gardini · 1985 to 2026
$15.3M
Targeted Combination Therapy for MelanomaP50CA174523 · NCI · WISTAR INSTITUTE · PI HERLYN, MEENHARD F · 2014 to 2018
$11.1M
The ARF Tumor SuppressorR01CA139319 · NCI · WISTAR INSTITUTE · PI MURPHY, MAUREEN E. · 2010 to 2019
$3.9M
Promotion of tumor invasion and pseudosenescence by the aging microenvironmentR01CA174746 · NCI · WISTAR INSTITUTE · PI WEERARATNA, ASHANI T · 2014 to 2018
$2.1M
Effect of the aged microenvironment on tumor dormancyR01CA207935 · NCI · WISTAR INSTITUTE · PI WEERARATNA, ASHANI T · 2017 to 2021
$2.0M
HLTF gene silencing: a novel determinant of sensitivity to autophagy inhibitionR01CA169134 · NCI · UNIVERSITY OF PENNSYLVANIA · PI AMARAVADI, RAVI K · 2013 to 2017
$1.7M
Histone modifications regulating phenotype plasticity: Role of non-canonical Wnt signalingK99CA208012 · NCI · WISTAR INSTITUTE · PI WEBSTER, MARIE RUTH · 2016 to 2017
$228k
NCI NIH HHS K99 CA208012NCI NIH HHS P01 CA114046NCI NIH HHS P30 CA010815NCI NIH HHS P30 CA016672NCI NIH HHS P50 CA093372NCI NIH HHS P50 CA174523NCI NIH HHS R01 CA139319NCI NIH HHS R01 CA169134NCI NIH HHS R01 CA174746NCI NIH HHS R01 CA207935NCI NIH HHS T32 CA009171
6 · The paper itself

Abstract

Autophagy mediates resistance to various anticancer agents. In melanoma, resistance to targeted therapy has been linked to expression of Wnt5A, an intrinsic inhibitor of β-catenin, which also promotes invasion. In this study, we assessed the interplay between Wnt5A and autophagy by combining expression studies in human clinical biopsies with functional analyses in cell lines and mouse models. Melanoma cells with high Wnt5A and low β-catenin displayed increased basal autophagy. Genetic blockade of autophagy revealed an unexpected feedback loop whereby knocking down the autophagy factor ATG5 in Wnt5A

Indexed as

AminoquinolinesAnimalsAutophagyAutophagy-Related Protein 5beta CateninBlotting, WesternCell Line, TumorFeedback, PhysiologicalGene Expression Regulation, NeoplasticHumansMelanomaMicePolyaminesReverse Transcriptase Polymerase Chain ReactionRNA InterferenceWnt-5a ProteinAminoquinolinesATG5 protein, humanAutophagy-Related Protein 5beta CateninLys01PolyaminesWnt-5a Protein

Identifiers

PMID28887323
PMCPMC5718045
OpenAlexW2751682201

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.